In 2014, the largest Ebola epidemic in history struck countries in West Africa, catching the attention of media outlets around the world and reaffirming the destructive power that viruses can have on unprepared civilizations. Viruses come in many shapes and sizes. From relatively inert bugs such as the common cold to dangerous, life-threatening infections like human immunodeficiency virus (HIV), influenza and dengue fever, viruses are found in almost every ecosystem on Earth, making them the most abundant type of biological entity on the planet.

Unlike bacteria, which are mostly harmless and often aid in the function of the human body, viruses are almost always bad news. These tiny organisms attach themselves to healthy cells within the body and, in many cases, reprogram those cells to create new viruses until the cells eventually burst and die. In other cases, viruses transform normal, healthy cells into malignant or cancerous cells. Although viruses are small (the largest virus is still smaller than even the smallest of bacteria), they are vicious. Most viruses target specific cells within the body, such as those in the liver, respiratory system or blood, causing serious, long-term health risks for infected individuals.

Because viruses hijack native cells and reprogram them in order to spread, effectively targeting a virus without harming its host organism’s cells is particularly difficult. When combined with viruses’ ability to mutate in order to counter attempts to inhibit their development, creating a universally effective antiviral medication becomes nearly impossible. Instead, pharmaceutical companies dodge mutations by taking preemptive measures. By administering small, relatively safe doses of viruses to patients, patients’ immune systems can be educated regarding particular viral infections, making future infections much less likely. These doses are known as vaccines.

Vaccines, much like viruses, come in a variety of shapes and sizes, and the world’s largest pharmaceutical companies are continuing to develop and innovative this preemptive treatment option in an effort to keep up with major viral threats. Vaccines are often extremely effective. Measles, for example, is one of the leading causes of death among young children, according to the World Health Organization, but a single dose of the MMR (measles, mumps and rubella) vaccine, which was developed in 1971 by Merck (NYSE: MRK), is 93 percent effective at preventing the deadly virus, according to the Centers for Disease Control and Prevention.

Not all vaccines are as consistently effective as the MMR vaccine, however. Influenza vaccines, such as those regularly developed by Sanofi (NYSE: SNY) and GlaxoSmithKline (NYSE: GSK), demonstrate the limitations of preemptive virus treatment. Because the influenza virus mutates very rapidly, flu shots are developed twice each year, but outbreaks of mutated strains still occur from time to time. To illustrate this, consider the 2009 flu pandemic, which involved the deadly H1N1 influenza virus, commonly known as swine flu. After patients are infected with an unforeseen virus mutation, vaccines are rendered totally ineffective, leaving biopharmaceutical companies to turn to alternative approaches to address these dangerous illnesses.

NanoViricides, Inc. (NYSE MKT: NNVC) is a nano-biopharmaceutical company that’s attempting to usher in a whole new era in medicine. The company’s innovative nanoviricide® antiviral therapeutics are nanomachines that are armed to destroy a particular type of virus. By programming information about a specific virus into the nanoviricide – similar to the postal address on an envelope – the company’s treatment fools a virus that’s already in a person into attaching to it. Shortly after attachment, the nanoviricide encapsulates the virus particle and absorbs its coat proteins. Without those proteins, the virus is unable to bind to a cell, rendering it neutralized and effectively destroyed.

Utilizing its versatile platform technology, NanoViricides is currently developing drugs against a number of viral diseases – including H5N1 bird flu, seasonal influenza, HIV, epidemic keratoconjunctivitis (EKC), hepatitis C, rabies, dengue fever and Ebola virus, among others. The company’s broad-spectrum nanoviricides, which it’s developing to combat several neglected tropical diseases, can bind to as many as 95 percent of known viruses, according to company data. NanoViricides’s most advanced product candidate, injectable FluCide™, is currently being studied in IND-enabling trials for the treatment of severe influenza with hospitalization.

In a quarterly report filed earlier this year, NanoViricides outlined its considerable progress in recent months. In particular, the company highlighted the advancement of its HerpeCide™ program, which it expects to contribute to the ongoing development of topical drugs to control herpes virus outbreaks for a number of indications – including oral lesions and shingles. Assuming positive results from its animal studies, NanoViricides expects these programs to result in extremely effective drugs.

According to its latest financial report, NanoViricides estimates that it has enough cash on hand to perform initial human clinical trials on at least one of its promising drug candidates, as well as advancing at least one additional candidate toward initial clinical trials. With HerpeCide and injectable FluCide currently leading the way, the company is in a favorable strategic position to put its promising therapeutic candidates to the test in the coming months, ahead of potential commercialization. For prospective shareholders, NanoViricides, complete with its innovative approach to targeted antiviral therapeutics, represents an extremely intriguing investment opportunity in the rapidly evolving biopharmaceutical industry.

For more information, visit www.nanoviricides.com

Transitioning to a healthy lifestyle is essential for developing a better quality of life and extending your lifespan. With so many cheap, quick and easy, fast food chains on every corner of America, sometimes that seems like a monumental task, but, in today’s world of smartphone technology and ‘app-hungry’ consumers, Content Checked Holdings, Inc. (OTC: CNCK) is aiding the health conscience shopper with its easy-to-use ContentChecked and SugarChecked apps.

The company’s apps were recently featured in the DIY Active article “Healthy Kitchen Tips: 4 Easy Steps” by clinical nutritionist Tara Zamani where she outlines a guide to healthy living using readily available tips, products, and technology. Zamani emphasizes the importance of getting into the habit of cooking and making it a priority in your life. Once you do this for a while, it becomes fun and is unlike any other activity because of the joys associated with feeling healthier from your own making and, of course, helping your family do the same.

Before jumping into the kitchen, you need the proper ingredients for a healthy concoction. Here is where she illustrates the significance of savvy shopping via ContentChecked’s family of innovative mobile apps. With the SugarChecked app, once you scan a food item, an alert is issued based on personal dietary sugar/sweetener preferences, and then the app provides you with a list of satisfactory alternatives. The ContentChecked app works very similarly, except that it alerts the user based on personal allergy settings and then offers a list of acceptable replacements.

The company’s goal is to continue building an environment that will foster healthier and happier lives through personally targeted information. The key to a healthier way of life is in the palm of your hand thanks to Content Checked Holdings. All you need to do is download the apps and start shopping.

For more information, visit the company’s website at www.ContentChecked.com.

In October, Dominovas Energy Corporation (OTC: DNRG) announced a landmark capital commitment of $1.2 billion in project financing to support the manufacture and deployment of its proprietary RUBICON™ solid oxide fuel cell (SOFC) system. This unprecedented commitment is expected to play a pivotal role in the company’s ongoing efforts to fulfill over 200MWs of signed and guaranteed power purchase agreements (PPAs) in the Democratic Republic of the Congo and allow for continued acquisition of additional PPAs throughout sub-Saharan Africa.

At the heart of DNRG’s recent performance is its cutting-edge multi-megawatt RUBICON™ SOFC system. The RUBICON™ is a fuel-flexible, highly efficient, and scalable approach to power generation. Taking into account that fuel sources vary from country to country, the RUBICON™ is able to incorporate a number of different fuels into its operation. In fact, DNRG states that the RUBICON™ will reform almost any hydrocarbon fuel into a suitable syngas composition, allowing for optimal stack electricity generation. Also, by implementing a thermal conversion process, DNRG’s technology is able to achieve a significant efficiency gain of roughly 60 percent over any combustion-based electricity production process.

In addition to improved efficiency, the RUBICON™ provides the means for additional value propositions through the flexibility of cogeneration. When generating power, the SOFC system produces useful heat and emits water, which can be further utilized for heating and cooling, providing an opportunity to improve overall system efficiency to more than 85 percent. When combined with the option to place power generation in the immediate proximity to the end-user in order to eliminate the high costs of infrastructure and transmission line maintenance, the RUBICON™ offers frontier markets around the globe an opportunity to greatly improve their power generation capacity in an affordable, efficient and environmentally-responsible manner.

For prospective shareholders, DNRG represents an opportunity to invest in the ongoing infrastructure development of countries in sub-Saharan Africa and around the world. According to a report by McKinsey & Company, sub-Saharan Africa currently includes seven countries with electrification of 50 percent or less, but that statistic is set to change. By 2040, the report estimates that demand for electricity will increase fourfold and more than 70 percent of the population will have access to reliable power. As DNRG prepares to fulfill its first PPA in the region in the coming months, this demand should place the company in a strong strategic position to promote sustainable financial growth.

For more information, visit www.dominovasenergy.com

Let us hear your thoughts: Dominovas Energy Corp. Message Boards

Moxian, Inc. (OTC: MOXC), a leader in online-to-offline marketing platforms, offers social marketing and promotion platforms to merchants who wish to promote their businesses through online social media. For five years, Moxian has delivered its platform to e-commerce operators, manufacturers, news media, payment providers, retail merchants, shopping mall operators, software developers and telecommunication and transportation providers from its base in Shenzhen, China.

Moxian’s products and services empower interactions between its merchant clients and its consumer users. The company designs its products and services to allow merchant clients to run advertising campaigns and promotions targeting customers. Its platform is also designed to entice users to return regularly and to encourage new users to subscribe to its website. In allowing merchant clients to study consumer behavior through data collected from a database of users’ activities, the company has focused on building a social customer relation management tool that allows business owners to engage in precision marketing.

The Moxian portfolio of products and services includes:

• Moxian+ App, an O2O business solution geared toward small and medium businesses that provides its users with a social media platform, which integrates entertainment, commerce, shopping and customer loyalty reward;
• A social marketing platform being designed and developed under the MO-Promo brand, which serves as an online sale promotion website for Moxian’s clients’ businesses; and
• MO-Reward, a reward giving back platform under development.

Moxian’s innovative platform and loyalty program is driving the company’s growth. In the summer of 2015, the company further solidified its market position when it entered into a subscription agreement with Beijing Xinhua Huifeng Equity Investment Centre, a limited partnership based in Beijing, China. To raise US$8.19 million. Moxian offered 8.19 million shares of its common stock to Xinhua Huifeng through a private placement. This sizable investment will allow Moxian to continue on the path its management has set for it and to continue to invest in its growth. It will also allow Xinhua Huifeng to help fund and contribute to Moxian’s future.

For more information, visit the company’s website at http://ir.moxian.com/html-en/

Let us hear your thoughts: Moxian, Inc. Message Board

Alzheimer’s and Autism are serious enough when the patient is confined to a controlled environment, but imagine when that person wanders off into the vast unknown with no caregiver to comfort and guide them safely home. This dreaded fear of losing a parent with Alzheimer’s or a child with Autism is very real for the families of more than 100 million people around the world today that require oversight due to some form of memory impairment. GTX Corp. (OTC: GTXO) is helping alleviate this fear with its GPS SmartSole technology.

The company’s tracking technology allows for the real-time monitoring of a loved one’s location with a simple shoe insole insert. The battery life is 2-3 days on a single charge, and the device show’s exactly where the wearer is located using a combination of satellite and cellular technology. Imagine the peace of mind associated with being able to keep track of your mom, dad, daughter or son through an app right on your smartphone.

Another significant feature of this technology is its ability to send notifications when the wearer leaves a predefined area. Just program the settings for the area around your house, school, senior living, hospital, etc., and enjoy a little more tranquility while your loved one gets the assistance they need. Operator assistance is also available 24/7 with SmartSoles.

Advances in technology like this are getting noticed around the globe, as this oversight problem is only getting worse. By 2050, the 100 million people mentioned earlier are expected to increase to 277 million, according to the 2013 World Alzheimer’s Report.

However, with every new problem comes a solution, or solutions. According to a recent US News and World Report article focusing on seven new technologies that will change the lives of seniors, SmartSoles, along with self-driving cars, nurse robots and smart homes, to name a few, will help mitigate some of the challenges associated with aging.

For more information, visit www.gtxcorp.com

Let us hear your thoughts: GTX Corp. Message Board

With Black Friday and Cyber Monday in the rear view mirror, there’s still enough time left in this year’s shopping season to head over the river and through the woods to the local mall for a few last minute gift items. For mom, dad and their growing family of four, however, this holiday shopping experience can include a level of anxiety to which only parents with young children can relate. Not only will their little ones have their senses bombarded with distracting sights, sounds and smells, their limited attention spans run counter to accomplishing the task at hand in any orderly and timely fashion.

Giggles N’ Hugs (OTC: GIGL) opened its first location over five years ago with a keen idea to curb some of the ‘what-to-do-with-kids’ dilemma when mall shopping beckons. Its concept to this day is truly unique, practical and healthy for the whole family. Promoting a healthy menu and surroundings aimed to captivate and meet the needs of children, the company’s plan is on track toward capturing a very lucrative niche for its shareholders. As of today, GIGL owns and operates three locations in greater Los Angeles, and has recently signed an agreement with a well-known New York investment bank to help expand its presence in the market.

The company’s healthy menu is gaining recognition and accolades among its customer base. High-quality organic food within a kid-friendly, casual dining area for adults featuring a huge play area is the model Giggles N’ Hugs has been successfully pursuing. Parents can relax while their children dine on the type of food their growing bodies need while enjoying play areas with birthday themes such as Superhero, Princess, Pirate and Mermaid, Jungle, Dinosaur and many others. Great reviews continue to roll in from customers and mall operators at each of its L.A. locations.

Giggles N Hugs, Inc. owns and operates kid-friendly restaurants with play areas for children 10 years old and younger in California. The company owns and operates a restaurant in the Westfield Mall in Century City, a restaurant in the Westfield Topanga shopping center in Woodland Hills, and a restaurant in the Glendale Galleria in Glendale, California. Founded in 2010, Giggles N Hugs, Inc. is based in Los Angeles, California.

For more information, please visit www.gigglesnhugs.com

Let us hear your thoughts: Giggles ‘N Hugs, Inc. Message Board

The global wearable technology market, worth only $750 million back in 2012, has maintained its show stopping growth pattern this year, spurred on by the planet’s biggest tech companies continuing to vie for the pole position in an ongoing race to become the dominant developer of what is seen as essentially the next mobile phone market. Transparency Market Research recently projected a forward CAGR of over 40 percent through 2018 for the space and leading tech-focused market research, analysis and advisory firm, International Data Corporation, estimates that more than 72 million units will ship by this year’s close, a whopping 173 percent jump over last year’s figure, and this figure is seen by IDC as growing to over 155 million units by 2019, on a CAGR of 42.6 percent.

One of the companies pushing the hardest is Intel (NASDAQ: INTC), which bought up Canadian high-tech sports eyewear maker Recon earlier this year. Intel even announced at its recent developer’s forum that the latest iteration of its America’s Greatest Makers contest will have its own long format reality TV show starting early next year.

The world’s biggest chip maker pumping the public for ideas clearly shows how aggressive the wearables game has become and even NASA is now leaning on the public in this way, running a contest to develop a smartwatch app for astronauts on the ISS using the Samsung (OTC: SSNLF) Gear 2 as a reference device for designs. This after units of Microsoft’s (NASDAQ: MSFT) augmented reality headset, HoloLens, never made it to the ISS, as they were lost earlier this year during the failed CRS-7 Falcon 9 resupply mission by Tesla (NASDAQ: TSLA) founder Elon Musk’s SpaceX.

According to emerging technology-focused independent market research and business intelligence firm IDTechEx, one of the big trends in wearables is the continuing efflorescence of advanced informatics as wearable electronics. This trend will naturally expand the footprint of wearables in the healthcare market considerably, with truly disruptive implementations in areas such as e-textiles promising billion dollar sales potential, especially for devices that capture the right mix of data capture, communication, and overall functionality. We are already seeing some of the first truly compelling fruits of this race, with companies like Philips (NYSE: PHG) Healthcare teaming up with Google (NASDAQ: GOOG; GOOGL) to merge Philips IntelliVue Solutions technologies with Google Glass, transferring real-time data directly to the eyepiece so that doctors can have a persistent HUD (heads-up display) feeding them patient vital signs, all without ever having to take their eyes off the procedure.

Philips, which developed the IntelliVue MX40 wearable patient monitor that can display real-time patient vital signs on its color touchscreen and yet is light and small enough for ambulatory patients to comfortably wear, has also teamed up with Accenture (NYSE: ACN) in order to fuse together big data and wearable tech in a solution targeted primarily at ALS patients. The proof of concept solution from Philips and Accenture ties together a wearable display with the Emotiv Insight Brainware, a 5-channel wireless headset that records brainwaves, resulting in a device that could provide a great deal of independence to ALS sufferers, as well as others with neurodegenerative diseases. There is a great deal of potential for real-time patient monitoring devices like this and the success of systems like the LifeWatch, a mobile phone connected remote cardiac monitoring wearable from the subsidiary of Switzerland-based telemedicine products and services provider LifeWatch AG (OTC: LFWWF), is a good indicator of how mobile-enabled healthcare wearables that can be used to safeguard lives will fare in coming years.

A new report out from Global Industry Analysts published by Research and Markets, indicates just how attractive the wearable medical device segment of the market is, with a 2020 projection of some $4.5 billion. One of the smaller and much more investor-accessible companies at the forefront of this segment is GTX Corp. (OTC: GTXO), developer of the patented GPS SmartSole®, which sits invisibly inside a piece of footwear and allows for real-time tracking of patients who have a tendency to wander, such as those with Alzheimer’s, dementia, autism, and TBI. Recently showcased in Munich at the Telefonica Digital Innovation Day 2015 and featured in AARP’s 2015 technology gear guide, the SmartSole even beat out Samsung’s Gear S at the 2015 CTIA “Hot for the Holidays” Super Mobility Awards in the Wearables, Health, Fitness and Wellness category, coming in second only to Microsoft’s smartwatch with heart rate monitor, the Microsoft Band.

Applications for the SmartSole however run far and wide beyond just healthcare. The device is quickly gaining ground in a variety of tracking roles, such as real-time monitoring of high value assets like foreign diplomats and other government employees, as well as high level executives. Former NFL pro Jack Brewer, who got his start with the Minnesota Vikings and was known as one of the top defensive backs and special teams players in the league, playing key leadership roles for the New York Giants and the Philadelphia Eagles before going on to found and be the CEO of The Brewer Group Companies, has even officially endorsed the SmartSole in this capacity. Brewer, whose career and charitable work constantly takes him all over the globe, uses the SmartSole as a way for family and colleagues to easily track his whereabouts, as well as view a detailed real-time trail of where he has been using the GTX Smart Locator app.

The SmartSole is an ingenious design, powerful enough to satisfy all the demands that consumers place upon such a solution, yet surreptitious enough to avoid the stigma cognitive impairment sufferers may experience, as well as detection by would-be kidnappers.

For more information, visit www.gtxcorp.com

Let us hear your thoughts: GTX Corp. Message Board

For over 10,000 years, the hemp plant has been a valuable crop used for a variety of purposes. From clothing and building materials to paper and health products, hemp played a key role in the formation of nations and the emergence of global powers. Up until 1776, many colonies passed laws to encourage farmers to grow the useful crop, and Virginia even passed a law that imposed a fine on those who didn’t plant hemp.

Years later, the Marihuana Tax Act of 1937 was passed, and taxes were imposed on the domestic production of industrial hemp crops. Just 20 years later, these taxes had effectively eliminated domestic hemp production, making it too expensive to compete with international operations. In 1970, the Marihuana Tax Act was repealed and replaced by the Controlled Substances Act, which mistakenly classified hemp as a schedule I substance and outlawed its production across the nation.

Despite bans on production, industrial hemp has been legal to import into the U.S. for years. According to a report by the Los Angeles Times, industrial hemp in Canada – a major supplier to the U.S. – is just shy of a $1 billion industry. In 2013, Canadian farmers were clearing profits in excess of $250 per acre, which, when compared to the $71 per acre that American farmers net from soy crops, could represent a major financial boost for the nation’s struggling agricultural industry.

While hemp production remains banned at the federal level, tremendous progress has been made in recent years toward correcting the ban. In 2014, President Obama signed a bill that removed hemp grown for research purposes from the Controlled Substances Act. Later that year, Congress blocked the Drug Enforcement Administration from using federal funds to interfere with state-legal industrial hemp programs. Since then, states have been taking it upon themselves to revitalize hemp production while studying the potential economic and ecological benefits.

Hemp, Inc. (OTC: HEMP), through wholly-owned subsidiary Industrial Hemp Manufacturing, LLC, is set to capitalize on the country’s growing hemp movement through the operation of the largest decortication plant in North America, which is located in Spring Hope, North Carolina. In a forward thinking move, the company’s management team initiated construction and installation activities at the 70,000-square-foot warehouse months ago in preparation for the imminent legalization of industrial hemp production in the state. Hemp, Inc. plans to complete the decortication plant by the end of the year, and this timing could be ideal to capitalize on North Carolina’s evolving regulatory atmosphere regarding industrial hemp.

Earlier this month, North Carolina Governor Pat McCrory passed Senate Bill 313, marking a significant step toward sustainable financial growth for Hemp, Inc. The purposes of the law are to “establish an agricultural pilot program for the cultivation of industrial hemp in the state… and to pursue any federal permits or waivers necessary to allow industrial hemp to be grown in the state.”

Hemp, Inc.’s decision to keep its decortication plant in North Carolina appears set to pay off in the coming months. For prospective shareholders, the company is an intriguing opportunity to capitalize on the impending reemergence of one of the world’s oldest and most useful crops.

For more information, visit www.hempinc.com

Let us hear your thoughts: Hemp, Inc. Message Board

On November 12, 2015, Georgia became the latest state to allow the use of marijuana for medical purposes. There are now twenty states that have laws permitting the use of cannabis for health reasons. They are Arizona, California, Connecticut, Delaware, Georgia, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, Rhode Island, and Vermont. Another four states – Alaska, Colorado, Oregon, and Washington – and the District of Columbia allow the recreational use of cannabis, and at least two more, Mississippi and Nebraska, have decriminalized the possession of marijuana for personal use.

Freedom Leaf, Inc. (OTC: FRLF) is taking the tide for decriminalization of marijuana at the flood. The groundswell of public support for the decriminalization of marijuana and the dismantling of laws prohibiting its use for medicinal and leisure purposes has been growing. A survey conducted by the PewResearchCenter in April 2015 found that 53% of Americans believe cannabis should be legalized, and it’s not just ordinary citizens. At least three U.S. presidents have admitted to smoking marijuana… even if they didn’t all inhale. Yet the drug remains on the federal government’s list of Schedule I drugs, defined as the most dangerous of the controlled substances.

Freedom Leaf, Inc aims to change that. The company has established a brand that will capitalize on the change in public acceptance of marijuana. The brand will capture America’s freedom-loving, anti-establishment spirit and monetize it by building a news, arts and entertainment business, with both in-print and online publications. Currently, the company publishes the Freedom Leaf magazine that disseminates information about marijuana, particularly legislative developments, to investors and members of the public. Its byline is The Good News in Marijuana Reform. But capitalizing on the artsy image of cannabis, the magazine also reports on the arts, fashion and lifestyles.

Freedom Leaf, Inc offers a variety of services that includes brand licensing and marketing, advertising, and business incubation. The Freedom Leaf brand will be licensed to enterprises that wish to market marijuana or associated products. The company will also offer other marketing services such as seminars, music festivals, and promotional material. Adverting space is available on the Freedom Leaf online properties which include a number of existing and under-construction websites, such as FreedomLeaf.com, MarijuanaNews.com, CannaSpa.com, Vegasterdam.com, CannabisSeminars.com, CampusCannabisDebate.com, Cannabis Business University and LadyCannabis.com. The company also intends to acquire and incubate new businesses entering the cannabis-hemp industry with the aim of later spin-off.

Estimates of growth of the marijuana industry give credibility to Freedom Leaf’s corporate objectives. A recent article in the Huffington Post reported that ‘marijuana is the fastest-growing industry in the United States’. It went on to state: ‘Researchers from The ArcView Group, a cannabis industry investment and research firm based in Oakland, California, found that the U.S. market for legal cannabis grew 74 percent in 2014 to $2.7 billion, up from $1.5 billion in 2013.’ In 2015, the market is expected to grow by over 30%. It appears that Freedom Leaf, Inc. is in the right place at the right time.

For more information, visit http://freedomleaf.com

Let us hear your thoughts: Freedom Leaf Inc. Message Board

Avant Diagnostics, Inc. is a company that focuses on the commercialization of proprietary microarray-based tests for the early detection of cancers, neurodegenerative diseases, and more. The company’s leading product is OvaDx®, a non-invasive pre-screening test that detects ovarian cancer by measuring the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. This is the market’s first large panel screening test designed to detect ovarian cancer early. With early detection, more treatment options become available for patients that should delay or prevent disease progression. OvaDx® would be an optional supplement to existing tests such as CA-125, OVA1, and transvaginal ultrasounds.

In October 2015, Avant Diagnostics received a notice that its previously purchased specimens had been approved to use in the upcoming validation study to support a pre-Submission package to the United States Food and Drug Administration (FDA). The company intends to start the FDA validation study shortly after completing calibration testing. Once that process is finalized, Avant Diagnostics will test the approved specimens as a basis for the submission package. The company hopes its innovative product can then begin its 510(k) trial.

In a news release, Gregg Linn, Avant’s chief executive officer and president, stated, “Avant continues to make steady progress towards its goal of obtaining FDA 510(k) clearance for OvaDx®. We intend to periodically communicate with our shareholders and markets as we progress through the FDA negotiations and through FDA’s review of our 510(k) submission.”

According to the American Cancer Society, 21,290 women are expected to be diagnosed with ovarian cancer in 2015 alone. Adding to that number are 14,180 deaths from the disease. Furthermore, 1 in 75 women are at risk for this disease, which is the fifth leading cause of female cancer deaths.

By developing effective pre-screening tests, like OvaDx®, Avant Diagnostics aims to greatly improve the quality of life among patients by giving them the opportunity for early treatment options.

For more information, visit www.avantdiagnostics.com

Let us hear your thoughts: Avant Diagnostics, Inc. Message Board